Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Cancer Patients

    September 2020 in “ JAMA dermatology
    Gregory S. Phillips, Morgan E. Freret, Danielle Novetsky Friedman, Sabrina Trelles, Oluwaseun Kukoyi, Azael Freites-Martínez, Robin Unger, Joseph J. Disa, Leonard H. Wexler, Christopher L. Tinkle, James Mechalakos, Stephen W. Dusza, Kathryn Beal, Suzanne L. Wolden, Mario E. Lacouture
    TLDR Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.
    The study assessed persistent radiation-induced alopecia (PRIA) in 71 cancer patients, revealing that PRIA significantly impacted quality of life, particularly emotionally. Alopecia severity was dose-dependent, with higher radiation doses leading to more severe cases. Topical minoxidil, 5%, improved hair density in 82% of patients, though only 16% achieved complete regrowth. Surgical interventions, including hair transplantation, provided more substantial and lasting results. The study highlighted the need for further research to develop effective preventive and therapeutic strategies for PRIA.
    Discuss this study in the Community →

    Cited in this study

    22 / 22 results

    Related

    1 / 1 results